tiprankstipranks
Trending News
More News >

Tactic Pharma LLC Insider Profile

4 Followers
Tactic Pharma LLC, Ten Percent Owner at Monopar Therapeutics Inc, holds 4.28M shares in Monopar Therapeutics Inc (Ticker: MNPR).
tipranks
Tactic Pharma LLC

Tactic Pharma LLC
Monopar Therapeutics Inc (MNPR)
Ten Percent Owner

Not Ranked
Tactic Pharma LLC has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$122M
100.00%
A breakdown of Tactic Pharma LLC's holdings

Insider Roles

Monopar Therapeutics Inc
(MNPR)
Ten Percent Owner
Roles that Tactic Pharma LLC holds in companies

Most Profitable Insider Trade

Stock:
Monopar Therapeutics Inc
(MNPR)
Rating:Informative Buy
Date:Dec 20, 2019 - Dec 20, 2020
Return:-78.80%
The most profitable trade made by Tactic Pharma LLC

Tactic Pharma LLC's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Monopar Therapeutics Inc
Feb 16, 2021
Ten Percent Owner
Uninformative Sell
1.83M
$121.66M
Success Rate for
MNPR
0 out of 1 profitable transactions on
MNPR
0%
Average Return for
MNPR
Average return per transaction on
MNPR
-78.80%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Dec 20, 2019
Informative Buy
$1.00M
-
$8.00
-78.80%
Feb 16, 2021
Uninformative Sell
$1.83M
-
$14.64
List of latest transactions for each holding click on a transaction to see Tactic Pharma LLC's performance on stock

Tactic Pharma LLC insider profile FAQ

What is the percentage of profitable transactions made by Tactic Pharma LLC?
The percentage of profitable transactions made by Tactic Pharma LLC is ―.
    What is the average return per transaction made by Tactic Pharma LLC?
    The average return per transaction made by Tactic Pharma LLC is ―.
      What stocks does Tactic Pharma LLC hold?
      Tactic Pharma LLC holds: MNPR stocks.
        What was Tactic Pharma LLC’s latest transaction?
        Tactic Pharma LLC latest transaction was an Uninformative Sell of $1.83M.
          What was Tactic Pharma LLC's most profitable transaction?
          Tactic Pharma LLC’s most profitable transaction was an Informative Buy of MNPR stock on December 20, 2019. The return on the trade was -78.80%.
            What is Tactic Pharma LLC's role in Monopar Therapeutics Inc?
            Tactic Pharma LLC's role in Monopar Therapeutics Inc is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.